HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin
Crossref DOI link: https://doi.org/10.2337/dc14-0024
Published Online: 2014-07-12
Published Print: 2014-08-01
Update policy: https://doi.org/10.2337/ada-journal-policies
Ahrén, Bo
Johnson, Susan L.
Stewart, Murray
Cirkel, Deborah T.
Yang, Fred
Perry, Caroline
Feinglos, Mark N.
